莱美药业(300006.SZ)取得两项药品注册证书
LummyLummy(SZ:300006) 智通财经网·2025-09-17 07:59

Core Viewpoint - The company, Laimei Pharmaceutical, has received approval from the National Medical Products Administration for two drugs: Nicorandil tablets (5mg) and Ketorolac Tromethamine injection (30mg/1ml) [1] Group 1: Drug Approvals - Nicorandil tablets are indicated for the treatment of angina pectoris [1] - Ketorolac Tromethamine injection is suitable for short-term treatment of moderate to severe acute postoperative pain [1]